Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ISRCTN74875961Phase 4Completed
Phase 4, randomised, open-label trial in coronary arteriosclerosis comparing Ivabradine with Metoprolol (2 arms). Primary endpoint: Heart rate reduction. Started Mar 2007; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ISRCTN74875961.